Stefane Vella, after a postdoctoral experience at the University of Pennsylvania, joined the medical staff at the Institute of Internal Medicine, Sapienza University of Rome, Italy, where he developed an extensive experience in the clinical management of patients with infectious diseases and with HIV/AIDS. His research interest has been directed towards the preclinical and clinical study of novel antiviral agents, the study of HIV resistance to antiretroviral drugs, the mechanisms of immune reconstitution, and the design and the conduct of strategic clinical trials aimed at perfecting antiretroviral therapy. He serves as the Director of the Department of Therapeutics and Medicines Evaluation in the Istituto Superiore di Sanità, Rome, Italy. He chaired, or participated to, many international clinical studies on antiretroviral therapy, and he has also been involved in the building of consensus international documents on the clinical management of HIV infection. Since 1996, he has been a Member of the Governing Council of the International AIDS Society (IAS) and an IAS President from 2000 to 2002. His group is currently conducting operational research in African countries, in particular on the implementation of programs to interrupt mother-to-child transmission of HIV, and to study improved delivery of antiretroviral therapy to adults and children.
Biography Updated on 15 January 2012